Key facts
- Latent’s last known valuation is $600.0M (Mar 2026).
- It has raised $93.1M; the latest was Early Stage VC ($80.0M) in Mar 2026.
- Notable investors include Y Combinator, General Catalyst, Spark Capital, Avra, Conviction Partners — 8 tracked in total.
- 1 investment vehicle was formed to buy Latent shares in the last 12 months, reporting $408K sold to 6 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Latent
- ·The full record, as it builds
Funding rounds
No funding rounds for Latent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Latent shares, reporting $408K sold to 6 investors. Most recent filing Apr 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Latent
Developer of a clinical automation platform designed to automate prior authorization processes and reduce administrative burden in medication access. The company's platform offers clinical artificial intelligence that reviews full patient records and generates evidence-based documentation so patients can get their life-saving meds, enabling healthcare providers to manage pharmacy-related workflows, ensuring timely access to prescribed treatments.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 49
- Website
- latenthealth.com/
- Ownership
- Privately Held (backing)
Latent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Latent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Latent in its N-PORT filings yet. We sweep new filings monthly.